Scientific Advisory Committee
The Scientific Advisory Committee, or SAC, is an independent body within CEPI and is one of CEPI's core governance groups alongside the Board, Investors Council, and Joint Coordination Group.
How they work
The SAC provides scientific support, advice, and challenge to the CEPI Leadership and Board on a range of scientific issues related to vaccine research and development and manufacturing to support the effective implementation of CEPI’s strategic objectives.
SAC Members
- Professor Alash'le Abimiku - International Research Center of Excellence, Institute of Human Virology, Nigeria
- Associate Professor Ifedayo Adetifa, Independent Public Health Expert, Kenya
- Dr Vincent Ahonkhai - Gwynedd Consultancy Group, LLC, USA
- Emeritus Professor Vineeta Bal - Indian Institute of Science Education and Research, Pune, India
- Dr Rick A. Bright - Bright Global Health, USA
- Dr Paula Bryant - National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA
- Assistant Professor Yunlong Cao - Peking University, China
- Dr Peter Dull - Bill & Melinda Gates Foundation, USA
- Professor Azra Ghani - Imperial College London, United Kingdom
- Dr Paula Goldin, Senior Medical Director PPD, Thermo Fisher, Argentina
- Mrs Rebecca Grais – Pasteur Network, France
- Professor Glenda E. Gray - South African Medical Research Council, South Africa
- Dr Beth-Ann Griswold Coller, Consultant, BCG Vaccine Consulting LLC, USA
- Dr Ana Maria Henao-Restrepo – World Health Organization, Switzerland
- Dr Emmanuel Hanon (Chair) - Vicebio, Belgium
- Professor Ken J. Ishii - International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Japan
- Professor Amine Kamen - McGill University, Canada
- Professor Michael King (Vice Chair) – University of Virginia, USA
- Professor Kevin Kee-Jong Hong, Korea mRNA Vaccine Initiative, Korea
- Dr Gary Kobinger – Galveston National Laboratory/Institute for Drug Discovery, University of Texas Medical Branch, USA
- Dr Phil Krause – World Health Organization, USA
- Dr Luciana C. C. Leite, Head of Recombinant BCG Laboratory, Instituto Butantan, Brazil,
- Professor Marc Lipsitch – Harvard T.H. Chan School of Public Health, USA
- Mr Dominique Maugeais – RH Solutions, France
- Dr Placide Mbala-Kingebeni, Head of Epidemiology and Global Health Department, Institut National de Recherche Biomedicale, Democratic Republic of Congo
- Mr Sly Ngoni Mutyavaviri, Senior GMP Inspector, Medicines Control Authority of Zimbabwe and SADC Medicines Regulatory Harmonisation Inspections Coordinator, SADC Medicines Regulatory Harmonisation, Zimbabwe
- Dr Laura Palomares Aguilera (Vice Chair) - Instituto de Biotecnología, Universidad Nacional Autónoma de México (UNAM), Mexico
- Dr Peter Paradiso - Paradiso Biologics Consulting, LLC, USA
- Dr Andre Siqueira, Public Health Researcher, Fundação Oswaldo Cruz (Fiocruz), Brazil
- Professor Stanley Plotkin - University of Pennsylvania, USA
- Dr Marie-José Quentin-Millet - MJQuentinMillet Consulting, France
- Professor Rino Rappuoli - Fondazione Biotecnopolo di Siena, Italy
- Lynda Stuart - Institute for Protein Design, USA
- Professor Linfa Wang - Duke-NUS Medical School, Singapore
- Professor George Warimwe - KEMRI-Wellcome Trust Research Programme, Kenya and University of Oxford, United Kingdom
Joint Coordination Group
Our Joint Coordination Group, or JCG, is a roundtable of independent institutions with an interest in seeing CEPI-funded vaccines successfully developed and deployed in an outbreak.
Portfolio Strategy and Management Board
The PSMB is the decision-making body accountable for identification, selection, management and evaluation of CEPI’s R&D and Manufacturing portfolio.
